Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases

Jean-Yves Winum, Alfonso Maresca, Fabrizio Carta, Andrea Scozzafava, Claudiu T. Supuran
  • Chemical Communications, January 2012, Royal Society of Chemistry
  • DOI: 10.1039/c2cc33415a